ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biology and function of exosomes in tumor immunotherapy

Liu, Can; Xia, Cong; Xia, Chenglai*南方医科大学
Biomedicine and Pharmacotherapy2023-12-31DOI: 10.1016/j.biopha.2023.115853
10阅读
引用收藏
分享

摘要

Exosomes are nano-scale extracellular vesicles that are found widely in various biological fluids. As messengers, exosomes deliver characteristic biological information from donor cells, facilitating their accumulation and subsequent transfer of information to tumor immune cells. Immunotherapy is a cutting-edge strategy for cancer therapy, but it has not yet reached its full potential owing to severe side effects and limited efficacy. Exosomes possess antigens and immunostimulatory molecules and can serve as cell-free vaccines to induce antitumor immunity. In addition, given their stability, low immunogenicity, and targeting ability, exosomes represent ideal drug delivery systems in tumor immunotherapy by delivering cargoes, including non-coding ribonucleic acids (RNAs), membrane proteins, chemotherapeutic agents, and immune cell death inducers. Exosomes can also be engineered to precisely target tumor cells. However, as a rising star in tumor immunotherapy, exosomes are also impeded by some challenges, including the lack of uniform technical standards for their isolation and purification, the need to improve exosomal cargo loading for efficient exosome delivery, and the expansion of clinical trials, which are currently in their infancy. Long-term, multi-center, and large-scale clinical trials are needed to evaluate the performance of exosomes in the future. Nonetheless, exosomes have demonstrated encouraging performance in tumor immunotherapy. In this review, we summarize the potential and challenges of exosomes in tumor immunotherapy, with the aim to shed light on exosomes as new-era tumor immunotherapy tools.

学科与关键词

关键词
ExosomesTumor immunotherapyTumor vaccineDrug delivery system
相关
加载中…
  • Exosomes as Carriers for Drug Delivery in Cancer Therapy
    Zeng, Weiping; Wen, Zhengbo; Chen, Honglin*; Duan, Yuyou*Pharmaceutical Research, 2023, 40(4): 873-887.被引 14
  • Engineered extracellular vesicles and their mimetics for cancer immunotherapy
    Liu, Chunping; Wang, Yichao; Li, Longmei; He, Dongyue; Chi, Jiaxin; Li, Qin; Wu, Yixiao; Zhao, Yunxuan; Zhang, Shihui; Wang, Lei*; Fan, Zhijin*; Liao, Yuhui*Journal of Controlled Release, 2022, 349: 679-698.被引 66
  • The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
    Li, Tianwei; Li, Xiaoqing; Han, Guiping; Liang, Ming; Yang, Zongrui; Zhang, Congyi; Huang, Shizhuan; Tai, Sheng*; Yu, Shan*Pharmaceutics, 2023, 15(1): 21.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomedicine and Pharmacotherapy
发表日期
2023-12-31
卷期
第 169 卷
页码
115853
DOI
10.1016/j.biopha.2023.115853
语言
MULTI-LANGUAGE
成果收录
SCIE

作者

  • L

    Liu, Can (第一作者)

    southern med univ

  • X

    Xia, Cong

    2 · dalian med univ

查看全部 3 位作者收起作者
  • X

    Xia, Chenglai (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417